Filters: Author is Friedland, Gerald [Clear All Filters]
"The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 34, no. 8 (2002): 1115-21. Abstract
"The place of prevention in HIV clinical care: a roundtable discussion." AIDS clinical care 14, no. 6 (2002): 49-53, 58.
"Report from the Tenth Retrovirus Conference. Clinical trials in resource-poor settings." AIDS clinical care 15, no. 4 (2003): 31-2.
"Report from the Tenth Retrovirus Conference. Tuberculosis." AIDS clinical care 15, no. 4 (2003): 32.
"The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 37, no. 4 (2003): 476-82. Abstract
"Antiretroviral treatment and research in resource-poor countries." Lancet 361, no. 9355 (2003): 435.
"Human immunodeficiency virus infection prevention: strategies for clinicians." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 36, no. 9 (2003): 1171-6. Abstract
"Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care." AIDS (London, England) 18, no. 7 (2004): 975-9.
"A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting." Journal of acquired immune deficiency syndromes (1999) 36, no. 4 (2004): 929-34. Abstract
"Use of total lymphocyte count for monitoring response to antiretroviral therapy." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 38, no. 2 (2004): 257-62. Abstract
"HAART for hospital health care workers--an innovative programme." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 94, no. 6 (2004): 423-7.
"Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 38 Suppl 5 (2004): S421-8. Abstract
"Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 13, no. 2 (2004): 163-80. Abstract
"Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care." AIDS (London, England) 18, no. 16 (2004): 2185-9. Abstract
"Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals." Clinical pharmacokinetics 44, no. 1 (2005): 99-109. Abstract
"Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8." The Journal of infectious diseases 191, no. 3 (2005): 324-32. Abstract
"Top stories of 2004. Nevirapine and efavirenz: similar efficacy, different toxicities, and better separately than combined." AIDS clinical care 17, no. 1 (2005): 5.
"The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 41, no. 7 (2005): 1027-34. Abstract
"Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction." AIDS (London, England) 19, no. 15 (2005): 1635-41. Abstract
"HIV drug resistance and HIV transmission risk behaviors among active injection drug users." Journal of acquired immune deficiency syndromes (1999) 40, no. 1 (2005): 106-9. Abstract
"A population-based and longitudinal study of sexual behavior and multidrug-resistant HIV among patients in clinical care." MedGenMed : Medscape general medicine 8, no. 2 (2006): 72. Abstract
"Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV." The Journal of antimicrobial chemotherapy 58, no. 6 (2006): 1299-302. Abstract
"Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S224-34. Abstract
"Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S235-46. Abstract
"Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 15, no. 1 (2006): 23-34. Abstract
"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa." Lancet 368, no. 9547 (2006): 1575-80. Abstract
"Tuberculosis and HIV-needed: a new paradigm for the control and management of linked epidemics." MedGenMed : Medscape general medicine 9, no. 3 (2007): 62.
"Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies." The Journal of infectious diseases 196 Suppl 1 (2007): S114-23. Abstract
"Tuberculosis and HIV coinfection: current state of knowledge and research priorities." The Journal of infectious diseases 196 Suppl 1 (2007): S1-3.
"Interaction between buprenorphine and atazanavir or atazanavir/ritonavir." Drug and alcohol dependence 91, no. 2-3 (2007): 269-78. Abstract
"Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa." The Journal of infectious diseases 196 Suppl 3 (2007): S482-90. Abstract
"Managing multiple and extensively drug-resistant tuberculosis and HIV." Expert opinion on pharmacotherapy 8, no. 8 (2007): 1035-7. Abstract
"Tuberculosis, drug resistance, and HIV/AIDS: a triple threat." Current infectious disease reports 9, no. 3 (2007): 252-61. Abstract
"Attitudes toward needle-sharing and HIV transmission risk behavior among HIV+ injection drug users in clinical care." AIDS care 20, no. 4 (2008): 462-9. Abstract
"Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa." The Journal of infectious diseases 198, no. 11 (2008): 1582-9. Abstract
"The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life." Journal of acquired immune deficiency syndromes (1999) 47, no. 2 (2008): 185-93. Abstract
"Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance." AIDS (London, England) 22, no. 1 (2008): 75-82. Abstract
"Protecting health care workers: the critical role of airborne infection control." The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 12, no. 6 (2008): 585.
"Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 46, no. 6 (2008): 941-5. Abstract
"Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial." Journal of acquired immune deficiency syndromes (1999) 49, no. 2 (2008): 142-50. Abstract
"Extensively drug-resistant tuberculosis: a new face to an old pathogen." Annual review of medicine 60 (2009): 307-20. Abstract
"Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community." Current opinion in infectious diseases 22, no. 1 (2009): 11-7. Abstract
"Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba study." Journal of acquired immune deficiency syndromes (1999) 50, no. 1 (2009): 37-43. Abstract
"Tuberculosis immune reconstitution inflammatory syndrome: drug resistance and the critical need for better diagnostics." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 48, no. 5 (2009): 677-9.
"Discovery of the function of the heart and circulation of blood." Cardiovascular journal of Africa 20, no. 3 (2009): 160.
"Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community." PloS one 5, no. 12 (2010): e15735. Abstract
"Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis." Journal of acquired immune deficiency syndromes (1999) 55 Suppl 1 (2010): S37-42. Abstract
"The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 100, no. 12 (2010): 808-9.
"Timing of initiation of antiretroviral drugs during tuberculosis therapy." The New England journal of medicine 362, no. 8 (2010): 697-706. Abstract
